Department of Oncology

DNA methylation signatures of sporadic colorectal cancer with microsatellite instability.

Ward R. et al, (2026), Epigenetics, 21

Developmental dynamics of ovine lung in health and cystic fibrosis at single-cell resolution

Tkachenko S. et al, (2026), Functional and Integrative Genomics, 26

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

Schietinger M. et al, (2026), Mater Today Bio, 40

Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation.

Elsner L. et al, (2026), Mol Ther Oncol, 34

Assessing the Benefit of Adjuvant Chemotherapy in Rectal Cancer: An International Real-World Analysis.

Hanna CR. et al, (2026), Clin Oncol (R Coll Radiol), 57

Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.

Shitara K. et al, (2026), ESMO Gastrointest Oncol, 13

Clinician and patient attitudes toward locoregional treatment of oligometastatic oesophago-gastric cancers: a mixed-methods study.

Lakha AS. et al, (2026), ESMO Gastrointest Oncol, 13

Can GLP-1RA be utilised for pre-operative liver optimisation prior to hepatectomy? A scoping review of MASLD evidence with surgical translation

Vaitha R. et al, (2026), Clinical Surgical Oncology, 5, 100136 - 100136

IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

Doultsinos D. et al, (2026), EMBO Mol Med

Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer.

Kishi K. et al, (2026), Int J Clin Oncol

PRMT5-mediated intron retention triggers innate and adaptive immunity against cancer.

Blaszczak W. et al, (2026), EMBO Mol Med

Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Pennel KAF. et al, (2026), J Exp Clin Cancer Res, 45

NMR metabolomics and glycomics for cancer detection in patients with non-specific symptoms: a prospective observational cohort study.

Kacerova T. et al, (2026), EBioMedicine, 131

Treatment of complex perianal fistulas with fistula laser closure : Application of the IDEAL 2A framework.

Marino MJ. et al, (2026), Wien Klin Wochenschr

Hypoxia increases the activity of oncolytic adenoviruses through HIF-2α-stimulated E1A expression.

Jacobus EJ. et al, (2026), Signal Transduct Target Ther, 11

Fully Automated Segmentation of Anatomical Subregions of the Thoracolumbar Spine on Computed Tomography.

Da Mutten R. et al, (2026), J Imaging Inform Med

pysigscore: gene signatures scoring across bulk and single-cell transcriptomics

Giacomello T. et al, (2026)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment, and follow-up of patients with hepatocellular carcinoma.

Tan CK. et al, (2026), ESMO Open, 11

Context-dependent efficacy of fibroblast activation protein-targeted radionuclide therapy (FAP-TRT): the dual role of CAFs.

Wu C. et al, (2026), Eur J Nucl Med Mol Imaging

Africa's emerging role in precision oncology: translational insights from the harnessing functional genomics in cancer research conference, Windhoek, 23-26 September 2025.

Rix CL. et al, (2026), BMC Proc, 20

Cookies on this website

Search results

Showing results for